All articles in Sleep Apnea

Insomniacs Failing Drugs Suffer from Sleep Apnea

Researchers at the Sleep and Human Health Institute and Maimonides Sleep Arts & Sciences, Ltd investigated drug failure in 1210 chronic insomnia patients and found 91% of those who completed sleep studies actually suffered from previously undiagnosed sleep apnea, a critical factor likely to be aggravating their insomnia.

Albuquerque, N.M., /2014 — Millions of people suffer from chronic insomnia. Complaining of stress, racing thoughts, and other relevant nighttime symptoms, these individuals feel incapable of sleeping all through the night. As their frustrations mount, they try drugstore or online over-the counter (OTC) remedies and many consult physicians who prescribe even stronger medications. Yet, most of these sleep aids fail to alleviate insomnia symptoms, leaving them Sleepless in “Fill-in the City.” The Sleep and Human Health Institute conducted research identifying the cause of drug failure in chronic insomniacs and found overwhelming evidence indicating that most treatment-seeking insomnia patients suffer from unrecognized sleep apnea.

Read More

UPMC offers brand new sleep apnea treatment

 Posted: 10:29 a.m. Monday, June 16, 2014


About 12 million people are missing out on a good night’s sleep every day.  Sleep apnea can leave patients tired and out of options.  But now, there’s a brand new treatment that’s making history at UPMC.

Channel 11′s Katherine Amenta has an exclusive look at this game-changer.

“You wake up with a headache, every morning,” said Denise Hoover.

Hoover has started every day in pain for the past 20 years.  Sleep apnea has been robbing her of a deep sleep.

“Your tongue basically blocks your airway and you stop breathing,” said Hoover.  “You wake up gasping.”

It’s so bad, Denise hasn’t even had a dream in two decades.  Instead, she’s awake and sometimes wrestling with a CPAP mask.

She finally went to see Dr. Ryan Soose at UPMC Mercy.  He had a brand new solution that could end up making medical history.

Read More

Diagnostic tools help patients overcome sleep disorders

 Virgil Pfeifle noticed after beginning a new job with an early morning shift that he was tired during the day. He was certain he wasn’t getting a full night’s sleep.

“I was really, really trying — fighting to stay awake in the morning and at work,” said Pfeifle, now 74, who started the job in 2006.

He underwent a sleep study, in which he slept overnight in a sleep lab with dozens of leads that monitored his respiration, heart rhythms, leg movements, snoring and several other processes, and was diagnosed with sleep apnea.

Pfeifle’s breathing stopped over and over again while he slept when a muscle closed his throat and prevented him from inhaling oxygen and expelling carbon dioxide.

Now Pfeifle uses a CPAP machine that keeps his airway open and allows him to breathe while he sleeps.

Read More

CPAP Benefits BP on Top of Weight Loss in Sleep Apnea

June 12, 2014
 Two new studies have shed more light on the role of continuous positive airway pressure (CPAP) on cardiovascular risk in patients with sleep apnea.

One study shows that in obese patients with moderate to severe sleep apnea, weight loss is the most important intervention and reduces inflammation, insulin resistance, dyslipidemia, and blood pressure. But CPAP had a meaningful incremental effect on blood pressure in fully adherent patients when used in addition to weight loss.

The second study provides more evidence that CPAP is effective for lowering blood pressure in patients with moderate to severe sleep apnea, even those with blood pressures in the normal range. But the study found no evidence of benefit of nocturnal oxygen supplementation on blood pressure in these patients.

Both studies are published in the June 12 issue of theNew England Journal of Medicine.

Read More

Sleep Apnea May Raise Risk of Diabetes

Up to 30 percent higher chance of developing blood sugar disease seen in study, but findings aren’t conclusive.

People who used the sleep apnea treatment fared

By HealthDay Reporter

FRIDAY, June 6, 2014 (HealthDay News) – A study of more than 8,600 people suffering from sleep apnea suggests a possible increased risk for developing diabetes, Canadian researchers report.

They sleep apnea results in less oxygen reaching cells in the body, less sleep and an increased heart rate, all of which are associated with a biological link to diabetes.

“Controlling for known risk factors for diabetes – including age, sex, weightsmoking,other medical problems and income status – patients with severe sleep apnea had a 30 percent higher risk of developing diabetes than those without sleep apnea,” saidlead researcher Dr. Tetyana Kendzerska. She’s with the University of Toronto’sInstitute of Health Policy, Management and Evaluation.

Obesity, an important risk factor or both diabetes and sleep apnea, was taken into account.

Read More

CPAP Compliance Key to Reducing Cardiovascular Risks of Sleep Apnea

Madison, Wisconsin – Long-term compliance with continuous positive airway pressure (CPAP) therapy may help prevent hypertension and reduce the risk of cardiovascular complications in adults diagnosed with obstructive sleep apnea (OSA), according to a study from the University of Wisconsin School of Medicine and Public Health.

OSA occurs when a person’s airway collapses or is blocked during sleep, resulting in paused or shallow breathing. CPAP therapy, the most common treatment for the disorder, uses a machine to increase air pressure to stop the airway from collapsing.

Obstructive sleep apnea is strongly associated with the development of hypertension, and patients with OSA are at an increased risk of cardiovascular morbidity and mortality.

Study Findings

Researchers followed 47 adults (50 years or younger) with recently diagnosed obstructive sleep apnea before and after three months of continuous CPAP therapy. Subjects who had high therapy compliance (more than 4 hours of use per night) showed significant improvements in systolic and diastolic blood pressures as well as peripheral arterial tone and stiffness – key markers for cardiovascular health.

Read More

Advanced Brain Monitoring Receives FDA Clearance for Night Shift Therapy – A Novel Treatment for Positional Obstructive Sleep Apnea

CARLSBAD, Calif.–(BUSINESS WIRE)–Advanced Brain Monitoring, Inc., a medical device company focused on improving healthcare for patients suffering from sleep and neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Night Shift, a therapy for positional obstructive sleep apnea.

“In our study we found that 70% of individuals with obstructive sleep apnea are at least twice as severe while sleeping on their back and may benefit from Night Shift therapy”

Worn on the back of the neck, Night Shift begins to vibrate when users begin to sleep on their back and slowly increases in intensity until a position change occurs. Night Shift is also an intelligent, interactive monitor that allows users to track its affect on snoring and sleep quality. Clinical study results showed that 89% of participants responded to Night Shift therapy, with the majority experiencing improved sleep quality, reduced loud snoring and improvements in sleep apnea symptoms.

Read More

Sleep society: Screen for apnea at first Medicare visit

By: ALICIA AULT, Clinical Endocrinology News Digital Network

 JUNE 3, 2014


MINNEAPOLIS – The American Academy of Sleep Medicine is pushing to have a simple sleep apnea questionnaire included in the initial Welcome to Medicare preventive care visit.

Including such a screening tool would help identify obstructive sleep apnea (OSA) when patients first join the Medicare program and thus improve the odds of diagnosing and treating the condition, said Dr. Timothy Morgenthaler, president of the AASM. Getting a handle on OSA could also reduce the potential that the beneficiary will develop related chronic conditions, and that will help Medicare curb expenditures, he said.

Dr. Timothy Morgenthaler


An estimated 20% of current Medicare beneficiaries have OSA. That number is expected to grow with the rising obesity rates, he said. Untreated OSA can increase the risk of hypertension, heart disease, type 2 diabetes, and stroke, said Dr. Morgenthaler, who is professor of medicine at the Mayo Clinic in Rochester, Minn.

Read More

An ancient molecule underlies the mechanism for sleep apnea and vascular problems

by Helen Dodson

An ancient molecule underlies the mechanism for sleep apnea and vascular problems

Credit: Shutterstock

(Medical Xpress)—The underlying mechanism of obstructive sleep apnea that causes damage to blood vessels and contributes to hypertension, stroke, and atherosclerosis has been identified by researchers from Yale and elsewhere. The finding points to potential biomarkers for early diagnosis and treatment of these conditions. The study appears in PLOS ONE.Obstructive sleep apnea (OSA) is characterized by recurrent upper airway obstruction while sleeping. It affects up to a fourth of all adults and is associated with increased risk of hypertension, stroke, and cardiovascular disease. But until now, the underlying mechanisms were not fully established.Current evidence suggests, the authors write, that , oxidative stress, and dysfunction in the inner lining of —the endothelium—play roles in the vascular complications of OSA. In addition, endothelial dysfunction is the earliest event in atherosclerosis and plays a pivotal role in all phases of that condition, including plaque rupture.
Read More

Study finds SleepMapper app and web-based solution improves therapy adherence for sleep apnea patients


June 2, 2014, 10:00 a.m. EDT

Patients using Philips Respironics’ SleepMapper achieved a 22 percent higher PAP therapy adherence than non-users

 ANDOVER, Mass., June 2, 2014 /PRNewswire/ – According to a new study released today at SLEEP 2014 by Philips Respironics , a division of Royal PhilipsPHG -0.03% (aex:PHI), patients using the SleepMappermobile app and web-based solution achieved a 22 percent higher positive airway pressure (PAP) therapy adherence rate than non-users. The results of the study further the evidence that patient engagement in care can lead to behavioral change and ultimately, better results and healthier populations.

Obstructive sleep apnea (OSA) is a serious medical condition that can lead to significant personal health consequences and increased overall healthcare costs. Treatment with PAP therapy is considered the gold standard for addressing OSA, but therapy is only effective if patients use their device as prescribed. Patients new to PAP therapy often struggle adapting to the equipment and lack of proper use puts patients’ health at risk and may also prompt insurers to refuse to pay for further therapy.

Read More